|
Ethmar International
Holding (EIH) brings
world-leading Institut
Marquès IVF center to Abu
Dhabi
(ABU DHABI)
-
Ethmar International Holding
(EIH), the UAE’s leading
progressive investment
holding, is partnering with
FutureLife group to
bring the internationally
renowned Institut Marquès
assisted reproductive
technology (ART) center to
Abu Dhabi. The new
state-of-the-art facility
will strengthen Abu Dhabi's
position as a global hub for
healthcare innovation and
excellence.
Founded
over a century ago, Institut
Marquès is a leader in
assisted reproduction,
recognized internationally
for its groundbreaking
advancements and success
rates in fertility
treatments. Its cutting-edge
embryology laboratories,
coupled with a
multidisciplinary team of
nearly 200 professionals,
including gynecologists,
embryologists, and
psychologists, have
positioned Institut Marquès
among the highest-performing
IVF providers globally,
delivering success rates of
up to 86%.
Currently
operating clinics in
Barcelona, Sabadell, Rome,
and Milan, Institut Marquès
will now bring its legacy of
European clinical excellence
and advanced technology to
Abu Dhabi. The new center
will integrate with Abu
Dhabi’s advanced healthcare
ecosystem, regulatory
leadership, and long-term
national healthcare vision.
Patients will have access to
a comprehensive suite of
fertility treatments and
services.
With
infertility affecting one in
six adults globally,
according to the World
Health Organization (WHO),
the introduction of Institut
Marquès to the UAE capital
is a significant milestone
in addressing this pressing
global health challenge. The
new center also aligns with
EIH's commitment to
supporting Abu Dhabi’s
strategic goals,
particularly in advancing
medical and health tourism,
and elevating local
healthcare capabilities and
patient experience.
EIH has mentioned that:
“Access to effective
fertility remains a
significant global
challenge. By bringing
Institut Marquès to Abu
Dhabi, EIH is underscoring
its commitment to supporting
the emirate’s ambition to
become a regional and global
healthcare hub. The strength
and legacy of Institut
Marquès in Europe
demonstrate its scalability,
clinical governance and
ability to deliver
consistently across multiple
markets.”
Institut
Marquès is part of the
FutureLife group, a global
leader in reproductive
medicine operating over 60
clinics across 16 countries,
bringing extensive expertise
and clinical excellence to
the collaboration. Abu Dhabi
will serve as the gateway
for Institut Marquès’
regional expansion, further
cementing the UAE capital as
a leader in advanced
reproductive medicine.
FutureLife group is
supported by Hartenberg, an
investment firm focused on
achieving investment growth
and long-term value and CVC
Capital Partners (“CVC”), a
leading global private
markets firm. CVC has a
history of investment in the
UAE and is committed to
investing further, to back
businesses that support
development across the
country.
Institut
Marquèsa Abu Dhabi is set to
open in 2026.
PRINT
THIS ARTICLE
|
